
Eli Lilly's CEO said a decade is "unlikely" to be enough for AI to cure cancer, pointing to human trials as the bottleneck rather than the technology itself.
Summaries like this, every morning.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
IREN stock has lost 63% in the past year and sits 74% below its June intraday high, even as AI Cloud revenue n…

CoreWeave announced a multi-year agreement with Wayve, which will train its foundation models for autonomous v…

Dubai Future Foundation announced DP World as the first strategic partner of SHIFFT, a self-driving logistics…

An RBA analysis by Mike Major found job postings fell across all groups since ChatGPT launched in late 2022, w…

Meituan released the weights for LongCat-2.5, a 1.6-trillion-parameter agent model trained on Chinese hardware…

A former Jindal Steel chief growth officer writes that he began using ChatGPT daily from December 2022, develo…
